Evercore ISI has upgraded CRISPR (CRSP) to outperform from in line, citing upcoming data catalysts. Read more here.

In a report released today, Ryan Kenny from Morgan Stanley maintained a Buy rating on Evercore Partners (EVR – Research Report), with a price ...

Confluent (NASDAQ:CFLT – Get Free Report) had its target price upped by Evercore ISI from $32.00 to $40.00 in a report ...

KBW analyst Aidan Hall reiterated a Buy rating on Evercore Partners (EVR – Research Report) today and set a price target of $339.00. The ...

Canada Goose (NYSE:GOOS – Get Free Report) had its price objective dropped by investment analysts at Evercore ISI from $13.00 ...

Fintel reports that on February 13, 2025, Evercore ISI Group downgraded their outlook for Trade Desk (NasdaqGM:TTD) from ...

Fintel reports that on February 11, 2025, Evercore ISI Group upgraded their outlook for TXNM Energy (NYSE:TXNM) from In-Line ...

Riverwater Partners Sustainable Value Strategy highlighted stocks like Evercore Inc. (NYSE:EVR) in its Q4 2024 investor letter. Headquartered in New York, New York, Evercore Inc. (NYSE:EVR ...

The comments echo recent worries from economists that the tariffs could cause a period of faster inflation and tepid growth, ...

Management highlighted key milestones for 2025, including the 10th anniversary of the Developing World strategy and the three-year anniversaries of several EMsights strategies. These milestones are ...